Q2 FY2026 · ended Jun 30, 2026 · Revenue $315,669, -72.2% YoY · Filed Aug 14, 2026
Osr Health, Inc. (OSRH) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $315,669 and a net loss of $1.0 million. As of Jun 30, 2026 it held $1.5 million in cash and investments and $2.7 million in total debt.
Revenue
$315,669
-72.2% vs year-ago quarter
Net income
$-1.00M
+80.8% vs year-ago quarter
Operating cash flow
$-2.42M
-401.6% vs year-ago quarter
Free cash flow
$-485,290
EPS
$-0.03
-219.4% vs year-ago quarter
Dividend per share
None
Shares outstanding
35.12M
+62.7% vs year-ago quarter
Net cash
$-1.18M
Q2 FY2026
Operating margin
-933.7%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- OSRH (OTC), OSRHW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bellevue, WA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1840425
- Former names
- OSR Holdings, Inc. (until Jun 11, 2026); Bellevue Life Sciences Acquisition Corp. (until Feb 13, 2025)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $315,669 | $484,057 | $381,269 | $627,747 | $1.1M |
| Operating income | -$3.0M | -$3.7M | -$6.4M | -$3.8M | -$5.2M |
| Net income | -$1.0M | -$3.5M | -$7.2M | -$3.2M | -$5.2M |
| Diluted EPS | -$0.03 | -$0.08 | -$0.23 | -$0.05 | $0.02 |
| Operating cash flow | -$2.4M | -$1.0M | -$1.1M | -$2.7M | -$482,609 |
| Free cash flow | — | — | — | — | -$485,290 |
| Total assets | $166.6M | $172.2M | $171.2M | $177.3M | $185.4M |
| Total liabilities | $41.7M | $44.8M | $44.2M | $43.1M | $46.3M |
| Stockholders' equity | $124.9M | $127.4M | $127.0M | $134.2M | $139.2M |
| Cash and investments | $1.5M | $1.6M | $1.7M | $2.2M | $1.6M |
| Total debt | $2.7M | $2.7M | $2.4M | $1.9M | $2.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Oct 28, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 16, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Other events
|
Aug 28, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Other events
|
Aug 25, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Aug 19, 2026 | Aug 19, 2026 |
All 226 Osr Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.